AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36209381 — intervention group
Group type: COMPARATOR
Intervention: Topical application of triamcinolone acetonide after microneedling (MN) treatment
Number of subjects: 30
Study 36209381 — intervention group
Group type: COMPARATOR
Intervention: Microneedling (MN)
Number of subjects: 30
Study 34562648 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Aminolaevulinic Acid Photodynamic Therapy (ALA PDT)
Number of subjects: 277
Study 34562648 — intervention group
Group type: COMPARATOR
Intervention: CO2 laser therapy
Number of subjects: 277
Study 35863669 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (0.5 mg/kg/d, maximum 40 mg/d, for 14 ± 2 days)
Number of subjects: 27
Study 32493401 — intervention group
Group type: EXPERIMENTAL
Intervention: GKT137831
Number of subjects: 0
Study 32493401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35561566 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 300
Study 35561566 — intervention group
Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 300
Study 34294595 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg/kg intravenously every 2 weeks for 12 months)
Number of subjects: 713
Study 34294595 — intervention group
Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 713
Study 34294595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study 34987000 — intervention group
Group type: EXPERIMENTAL
Intervention: Choose Your Own Adventure (CYOA) presentation format
Number of subjects: 144
Study 34987000 — intervention group
Group type: COMPARATOR
Intervention: Linear case format
Number of subjects: 144
Study 34987000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formats
Number of subjects: 144
Study 34423354 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 70
Study 34423354 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine
Number of subjects: 70
Study 34423354 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl and Lignocaine
Number of subjects: 70
Study 32967873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous haloperidol 2.5 mg every 8 hours, titrated to a maximum of 5 mg every 8 hours until delirium resolution or ICU discharge.
Number of subjects: 0
Study 32967873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32967873 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study 35501469 — intervention group
Group type: EXPERIMENTAL
Intervention: Real cerebellar tDCS
Number of subjects: 20
Study 35501469 — intervention group
Group type: COMPARATOR
Intervention: Sham cerebellar tDCS
Number of subjects: 20
Study 34181750 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/day for 10 weeks)
Number of subjects: 37
Study 34181750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 34181750 — intervention group
Group type: COMPARATOR
Intervention: Budesonide and Placebo (post hoc analysis)
Number of subjects: 37
Study 36041308 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee extensor muscle steadiness (measured as coefficient of variance [%] and peak power frequency [Hz])
Number of subjects: 177
Study 36041308 — intervention group
Group type: EXPERIMENTAL
Intervention: Coefficient of variance of muscle steadiness
Number of subjects: 177
Study 36041308 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak power frequency of muscle steadiness
Number of subjects: 177
Study 34723163 — intervention group
Group type: EXPERIMENTAL
Intervention: C21 (100 mg bid for 7 days)
Number of subjects: 106
Study 34723163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 34723163 — intervention group
Group type: EXPERIMENTAL
Intervention: C21
Number of subjects: 106
Study 35409775 — intervention group
Group type: EXPERIMENTAL
Intervention: E-training
Number of subjects: 100
Study 35409775 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face training
Number of subjects: 100
Study 33548494 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 0
Study 33548494 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 32797089 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neural network for diagnosing MR images of tumors of the hand
Number of subjects: 221
Study 32797089 — intervention group
Group type: COMPARATOR
Intervention: Ground truth analysis and manual analysis by a radiologist
Number of subjects: 221
Study 33656188 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed facial flap simulator
Number of subjects: 0
Study 33656188 — intervention group
Group type: COMPARATOR
Intervention: Traditional paper facial flap exercise (Control)
Number of subjects: 0
Study 33040002 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (hyperuricaemia treatment)
Number of subjects: 548
Study 33040002 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 548
Study 32598683 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs + Injectran (Chondroitin sulfate) 200 mg I.M. every other day No. 25
Number of subjects: 125
Study 32598683 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs + Fermatron 1% 2 ml I.A. with an interval of 7 days No. 3
Number of subjects: 125
Study 32598683 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs + Injectran 200 mg I.M. every other day No. 25 + Fermatron 1% 2 ml I.A. with an interval of 7 days No. 3
Number of subjects: 125
Study 32598683 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (control group)
Number of subjects: 125
Study 35091707 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystotome-assisted prechop phacoemulsification surgery (CAPPS)
Number of subjects: 64
Study 35091707 — intervention group
Group type: COMPARATOR
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 64
Study 33839890 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic clipping closure after colorectal ESD
Number of subjects: 155
Study 33839890 — intervention group
Group type: COMPARATOR
Intervention: Non-closure after colorectal ESD
Number of subjects: 155
Study 32204146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 50
Study 32204146 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 35603597 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0
Study 35603597 — intervention group
Group type: COMPARATOR
Intervention: Tenecteplase
Number of subjects: 0
Study 32871505 — intervention group
Group type: EXPERIMENTAL
Intervention: High social support
Number of subjects: 0
Study 32871505 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium social support
Number of subjects: 0
Study 32871505 — intervention group
Group type: EXPERIMENTAL
Intervention: Low social support
Number of subjects: 0
Study 32871505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 0
Study 35157497 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity monitoring with triage visits triggered by a 20% decrease in daily steps or 20% increase in heart rate.
Number of subjects: 40
Study 35157497 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity monitoring with triage visits.
Number of subjects: 40
Study 35157497 — intervention group
Group type: COMPARATOR
Intervention: Observation group (no active monitoring).
Number of subjects: 40
Study 33880614 — intervention group
Group type: EXPERIMENTAL
Intervention: TRS2�P risk scoring system
Number of subjects: 2611
Study 33582664 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (2 mg oral bolus followed by 0.5 mg b.i.d. for 5 days)
Number of subjects: 194
Study 33582664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 33582664 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 194
Study 33789792 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 15% with fracture angle (FA) of 40°
Number of subjects: 12
Study 33789792 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 15% with fracture angle (FA) of 60°
Number of subjects: 12
Study 33789792 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 20% with fracture angle (FA) of 40°
Number of subjects: 12
Study 33789792 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior wall fragment size (FS) of 25% with fracture angle (FA) of 40°
Number of subjects: 12
Study 36163722 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin 500 mg per oral capsule twice daily for 1 month plus nutritional standard of care (SOC)
Number of subjects: 30
Study 36163722 — intervention group
Group type: COMPARATOR
Intervention: Nutritional standard of care (SOC) only
Number of subjects: 30
Study 32003750 — intervention group
Group type: EXPERIMENTAL
Intervention: Precious app with digitalized motivational interviewing and gamification
Number of subjects: 12
Study 32003750 — intervention group
Group type: EXPERIMENTAL
Intervention: Precious app
Number of subjects: 12
Study 33606431 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 86
Study 33606431 — intervention group
Group type: COMPARATOR
Intervention: Chloral hydrate
Number of subjects: 86
Study 36338456 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic decolonization (topical chlorhexidine gluconate, intranasal mupirocin, oral rifampin, and oral doxycycline)
Number of subjects: 98
Study 36338456 — intervention group
Group type: COMPARATOR
Intervention: Standard decolonization (topical chlorhexidine gluconate and intranasal mupirocin)
Number of subjects: 98
Study 36338456 — intervention group
Group type: COMPARATOR
Intervention: Standard decolonization
Number of subjects: 98
Study 36338456 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic decolonization
Number of subjects: 98
Study 36338456 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic decolonization vs Standard decolonization
Number of subjects: 98
Study 34371442 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of androgen deprivation therapy (ADT)
Number of subjects: 198
Study 34371442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent docetaxel administration
Number of subjects: 198
Study 34371442 — intervention group
Group type: COMPARATOR
Intervention: Suspension of androgen deprivation therapy (ADT)
Number of subjects: 198
Study 33212360 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support intervention
Number of subjects: 110
Study 33212360 — intervention group
Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 110
Study 32438639 — intervention group
Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ), 16 ounces daily for 24 weeks
Number of subjects: 36
Study 32438639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 36404282 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted group cognitive-behavioral therapy (CBT) program
Number of subjects: 66
Study 36404282 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 66
Study 33452722 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed 3D real-time MRI method using randomized, variable-density, stack-of-spiral sampling
Number of subjects: 2
Study 33452722 — intervention group
Group type: COMPARATOR
Intervention: Original 3D real-time MRI method
Number of subjects: 2
Study 33452722 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed 3D real-time MRI method
Number of subjects: 2
Study 32732374 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 35
Study 32732374 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 35
Study 32732374 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 35
Study 35868017 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW‐HIIT (n=13), consisting of 5 × 1 min cycle ergometer intervals (14 min per session total duration) at 80% to 95% HR peak (two sessions per week for 12 wk)
Number of subjects: 27
Study 35868017 — intervention group
Group type: COMPARATOR
Intervention: SHAM (n=14), performing light physical mobilization exercises
Number of subjects: 27
Study 35612762 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (STA trial)
Number of subjects: 21
Study 35612762 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC trial)
Number of subjects: 21
Study 35612762 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (EXER+STA and EXER+PLAC trials)
Number of subjects: 21
Study 35612762 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins withdrawal
Number of subjects: 21
Study 35612762 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 21
Study 32075665 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly haemodialysis sessions
Number of subjects: 88
Study 32075665 — intervention group
Group type: COMPARATOR
Intervention: Thrice-weekly haemodialysis regimen
Number of subjects: 88
Study 36342245 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 174
Study 36342245 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 174
Study 33016677 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol
Number of subjects: 150
Study 33016677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 32346715 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implantation after minimally invasive extraction
Number of subjects: 86
Study 32346715 — intervention group
Group type: COMPARATOR
Intervention: Delayed implantation after minimally invasive extraction
Number of subjects: 86
Study 36352473 — intervention group
Group type: EXPERIMENTAL
Intervention: DISCOVER intervention (school-based stress workshop programme)
Number of subjects: 0
Study 33507684 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radical hysterectomy (LRH)
Number of subjects: 30
Study 33507684 — intervention group
Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 30
Study 32252619 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with trunk rehabilitation
Number of subjects: 28
Study 32252619 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping with trunk rehabilitation
Number of subjects: 28
Study 35771894 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use during last sexual intercourse
Number of subjects: 600
Study 35771894 — intervention group
Group type: COMPARATOR
Intervention: Experiencing physical violence by sexual partners
Number of subjects: 600
Study 35771894 — intervention group
Group type: COMPARATOR
Intervention: Ever using drugs of addiction
Number of subjects: 600
Study 34931773 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed implant overdentures
Number of subjects: 28
Study 34931773 — intervention group
Group type: COMPARATOR
Intervention: Conventional implant overdentures
Number of subjects: 28
Study 32340632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis containing Δ‐9‐tetrahydrocannabinol (THC) and negligible levels of CBD (Cann-CBD)
Number of subjects: 57
Study 32340632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis containing THC and CBD (Cann+CBD)
Number of subjects: 57
Study 32340632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cann-CBD
Number of subjects: 57
Study 32340632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 32659510 — intervention group
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 1272
Study 616191207 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue management education (six topics: pain management, nutrition management, sleep hygiene, anxiety management, light exercise, energy conservation)
Number of subjects: 81
Study 616191207 — intervention group
Group type: COMPARATOR
Intervention: Nursing care standard (control group)
Number of subjects: 81
Study 35351693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30
Study 35351693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34784131 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite with lidocaine (CaHA (+); Radiesse&reg; (+))
Number of subjects: 180
Study 34784131 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed treatment)
Number of subjects: 180
Study 35486418 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy for insomnia (ICBT‐i)
Number of subjects: 54
Study 35486418 — intervention group
Group type: COMPARATOR
Intervention: Applied relaxation (active control)
Number of subjects: 54
Study 35486418 — intervention group
Group type: COMPARATOR
Intervention: Both ICBT‐i and applied relaxation
Number of subjects: 54
Study 33826992 — intervention group
Group type: EXPERIMENTAL
Intervention: Written expressive disclosure (WED) about IBS
Number of subjects: 189
Study 33826992 — intervention group
Group type: EXPERIMENTAL
Intervention: Written expressive disclosure (WED) (combined group)
Number of subjects: 189
Study 33826992 — intervention group
Group type: COMPARATOR
Intervention: Control group (writing about daily activities)
Number of subjects: 189
Study 33826992 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (WED and control)
Number of subjects: 189
Study 34534130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis Transition And Recovery support (n = 349)
Number of subjects: 691
Study 34534130 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (n = 342)
Number of subjects: 691
Study 34534130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis Transition And Recovery support
Number of subjects: 691
Study 34534130 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 691
Study 33533532 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVS)
Number of subjects: 131
Study 33533532 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 131
Study 32392279 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body mass index (BMI)
Number of subjects: 379708
Study 32392279 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher waist-hip ratio
Number of subjects: 379708
Study 32392279 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability of type 2 diabetes (highest quartile)
Number of subjects: 379708
Study 35162424 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated segmentation using U-Net convolutional neural network (CNN)
Number of subjects: 150
Study 35162424 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated segmentation using U-Net CNN
Number of subjects: 150
Study 33392952 — intervention group
Group type: EXPERIMENTAL
Intervention: Momentary increases in stress appraisal
Number of subjects: 37
Study 33392952 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress appraisal ratings of 0.50 SD higher than average
Number of subjects: 37
Study 33392952 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 0.25 increments in momentary stress appraisal
Number of subjects: 37
Study 33392952 — intervention group
Group type: EXPERIMENTAL
Intervention: Work/school stressors and interpersonal stressors
Number of subjects: 37
Study 32534135 — intervention group
Group type: EXPERIMENTAL
Intervention: Review group (expert panel recommendations)
Number of subjects: 114
Study 32534135 — intervention group
Group type: COMPARATOR
Intervention: Nonreview group (referring surgeon's preference)
Number of subjects: 114
Study 32534135 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recommendations from surgeons
Number of subjects: 114
Study 35842062 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) therapy with pneumatic cuff set to 80% limb occlusion pressure, performed 5 days per week for two weeks
Number of subjects: 45
Study 35842062 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 45
Study 35842062 — intervention group
Group type: EXPERIMENTAL
Intervention: Both BFR and control groups
Number of subjects: 45
Study 34834540 — intervention group
Group type: COMPARATOR
Intervention: Standard escitalopram dosing
Number of subjects: 132
Study 34834540 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosing based on validated CYP2C19 phenotypes for escitalopram metabolism
Number of subjects: 132
Study 35168915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist-led smartphone application plus usual care
Number of subjects: 124
Study 36011930 — intervention group
Group type: EXPERIMENTAL
Intervention: HEUR-L (heuristic learning)
Number of subjects: 28
Study 36011930 — intervention group
Group type: COMPARATOR
Intervention: PRES-T (prescriptive teaching)
Number of subjects: 28
Study 36011930 — intervention group
Group type: EXPERIMENTAL
Intervention: HEUR-L
Number of subjects: 28
Study 36011930 — intervention group
Group type: COMPARATOR
Intervention: PRES-T
Number of subjects: 28
Study 36011930 — intervention group
Group type: EXPERIMENTAL
Intervention: HEUR-L and PRES-T
Number of subjects: 28
Study 32011181 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 22
Study 32011181 — intervention group
Group type: COMPARATOR
Intervention: Placebo (300 mg of corn-starch)
Number of subjects: 22
Study 35477683 — intervention group
Group type: EXPERIMENTAL
Intervention: rds-ccPAS-1500 (1500 pulses per session)
Number of subjects: 50
Study 35477683 — intervention group
Group type: EXPERIMENTAL
Intervention: rds-ccPAS-750 (750 pulses per session)
Number of subjects: 50
Study 35477683 — intervention group
Group type: COMPARATOR
Intervention: Single-site stimulation over the right dlPFC (1500 pulses per session)
Number of subjects: 50
Study 35477683 — intervention group
Group type: COMPARATOR
Intervention: Single-site stimulation over the right PPC (1500 pulses per session)
Number of subjects: 50
Study 32533264 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading of strategic mini-implants
Number of subjects: 76
Study 32533264 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading of strategic mini-implants
Number of subjects: 76
Study 36092959 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial step‐down therapy (imipenem/cilastatin)
Number of subjects: 65